Running is good for your health. Medical experts and the general public agree on this.

The LIH is not only a privileged research partner in Luxembourg, but also worldwide as a lead institution in large-scale collaborative initiatives.

WEBINAR: Lecture series Cancer Research: "Challenges in brain tumor immunotherapy"- Prof Michael Platten

Hypoxia, a decrease in the oxygen pressure, is a major factor developed in the microenvironment of all solid tumors. Tumor cells are able to adapt to hypoxic stress by activating multiple resistance mechanisms, which collectively contribute to the failure of conventional cancer treatments, such as chemo and radiation therapy. However, data underlining the tangible impact of hypoxia on the efficacy of immunotherapy are still missing.

Lecture series Infection & Immunity: "Spontaneous protein crystallization as a treatable trait in asthma"- Prof Bart Lambrecht

On Monday, September 14th, the Minister of Higher Education and Research, Claude Meisch, the Minister of Health, Paulette Lenert, and the Research Luxembourg (RL) COVID-19 Task Force held a press conference in Dudelange to officially conclude the first phase of the large-scale testing, led by the Luxembourg Institute of Health together with the Research Luxembourg community. The operations of the second phase have been handed over to the Health Directorate of the Ministry of Health and will start mid-September.

GOOD CLINICAL PRACTICE - Professional courses: How to write a clinical research protocol for a successful project

Lecture series Infection & Immunity: "How IL-17 regulate CNS autoimmunity via modulation of gut microbiota"- Prof Ari Waisman

Dr Guy Fagherazzi from the LIH Department of Population Health (DoPH) contributed to an international cohort study aiming to investigate the link between plasma vitamin C and carotenoids with the risk of developing type 2 diabetes.